MJNA - Medical Marijuana's Kannaway reports largest revenue month for Japan division

Medical Marijuana ( OTCPK:MJNA ) subsidiary Kannaway reported its largest revenue month in the company's history for its Japan division in June 2022.

Kannaway specializes in the sales and marketing of hemp-based botanical products. It established operations in Japan in 2019 and has seen rapid growth since then and to date in 2022.

Medical Marijuana CEO Blake Schroeder stated, "This year has been phenomenal for Kannaway in Japan. The company has increased sales every month in 2022 so far and we look forward to continuing this trend. Reporting indicates that the Japanese government is considering easing some of its regulations on how CBD is sold in the country, and this would allow for increased opportunity for Kannaway in the marketplace."

For further details see: